Table 2. Demographic and clinicopathologic characteristics of the study population.

Factor	Number of patients ( N =101)
Age
50–59	35 (35%)
60–69	50 (49%)
70–75	16 (16%)
Tumour size (mm)
<20	48 (48%)
20–49	46 (46%)
⩾50	7 (7%)
Tumour grade
1	15 (15%)
2	62 (61%)
3	24 (24%)
Axillary nodal stage
N0 (negative)	82 (81%)
N1 (1–3 nodes positive)	19 (19%)
ER status (H score)
<10	1 (1%)
10–99	8 (8%)
100–199	49 (49%)
⩾200	43 (43%)
PR status (%)
<5	22 (22%)
5–39	24 (24%)
40–79	25 (25%)
⩾80	30 (30%)
Ki67%
<10	41 (41%)
10–19	36 (36%)
⩾20	24 (24%)